Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway

Xinna Zhang1, Guohui Wan, Sizolwenkosi Mlotshwa

  • 1Department of Biological Sciences and Center for Colon Cancer Research, University of South Carolina, Columbia, SC 29208, USA.

Cancer Research
|July 30, 2010
PubMed

Insights

MicroRNA-16 (miR-16) regulates Wild-type p53-induced phosphatase 1 (Wip1) expression, impacting DNA damage response and mammary tumorigenesis. Downregulation of miR-16 in cancer stem cells promotes tumor growth and chemoresistance.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Wild-type p53-induced phosphatase 1 (Wip1) is an oncogene overexpressed in cancers, inhibiting ATM/ATR-p53 DNA damage signaling.
  • Wip1 dephosphorylates DNA damage proteins, reversing cell cycle checkpoints and is transcriptionally induced by p53.

Purpose of the Study:

  • To investigate the temporal and functional regulation of Wip1.
  • To identify regulatory mechanisms of Wip1 in DNA damage response and mammary tumorigenesis.

Main Methods:

  • Identification of microRNA-16 (miR-16) as a negative regulator of Wip1 mRNA.
  • Analysis of miR-16 induction kinetics post-DNA damage.
  • Examination of miR-16 expression in mammary tumor stem cells.
  • Assessment of miR-16 or Wip1 inhibition effects on mammary tumor stem cell self-renewal and growth.
  • Evaluation of miR-16 effects on breast cancer cell chemosensitivity.

Main Results:

  • miR-16 directly targets and downregulates Wip1 expression.
  • miR-16 is induced immediately after DNA damage, delaying Wip1 protein increase and ensuring functional DNA damage response.
  • miR-16 is downregulated in mammary tumor stem cells.
  • Overexpression of miR-16 or Wip1 inhibition suppressed mammary tumor stem cell growth and enhanced chemosensitivity.

Conclusions:

  • miR-16 plays a crucial role in regulating Wip1 phosphatase during DNA damage response.
  • Dysregulation of the miR-16/Wip1 axis contributes to mammary tumorigenesis and chemoresistance.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...